Clinical trials
Not yet recruiting Hyperlipidemias trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 20 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Addpharma Inc. | 2 |
| China National Center for Cardiovascular Diseases | 2 |
| Beijing Anzhen Hospital | 1 |
| Chinese PLA General Hospital | 1 |
| Corsera Health | 1 |
| Duke University | 1 |
| Eva Cubric | 1 |
| First Affiliated Hospital of Xinjiang Medical University | 1 |
| Fundación Santa Fe de Bogota | 1 |
| Hacettepe University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 28 |
| Hypertension | 8 |
| Diabetes Mellitus | 5 |
| Hypertriglyceridemia | 3 |
| Hypercholesterolemia | 2 |
| Metabolic Syndrome | 2 |
| Obesity | 2 |
| Overweight | 2 |
| Acute Coronary Syndrome | 1 |
| Atherosclerosis | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.